post acne erythema. Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: people with persistent post acne erythema that did not improve for at least 3 months in the age range of 16 to 40 years
Exclusion criteria
Exclusion criteria: coagulation disorders such as DIC ,pulmonary embolism,stroke,DVT suffering from cancers sensitivity to tranexamic acid in previous use consumption of drugs that interfere with the use of tranexamic acid (anticoagulants,estrogenic drugs,tretinoin and anti inhibitory coagulation concentrates ) pregnancy,breastfeeding and the decision to become pregnant oral and topical use of retinoids in the last 6 months prone to keloid formation photosensitivity the use of exfoliating topical drugs including AHA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema improvment on the right and left side of the face. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Scale of Clinician erythema assessment.;Patient satisfaction from treatment on the right and left side compared to before. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Asking the patient to choose a number from 1 (low) to 4 (very high) ,from the level of satisfaction with the treatment on each side of face. | — |
Secondary
| Measure | Time frame |
|---|---|
| The side effects. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Questions and comparisons. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences